Cardinal Health, Inc. (NYSE:CAH) Shares Purchased by Vestor Capital LLC

Vestor Capital LLC raised its position in Cardinal Health, Inc. (NYSE:CAH) by 197.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 158,508 shares of the company’s stock after purchasing an additional 105,131 shares during the quarter. Cardinal Health comprises approximately 1.4% of Vestor Capital LLC’s investment portfolio, making the stock its 18th biggest holding. Vestor Capital LLC owned 0.07% of Cardinal Health worth $17,518,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in CAH. Point72 Asset Management L.P. bought a new stake in Cardinal Health during the second quarter worth approximately $90,440,000. Acadian Asset Management LLC grew its holdings in shares of Cardinal Health by 19.1% in the 1st quarter. Acadian Asset Management LLC now owns 3,723,159 shares of the company’s stock worth $416,585,000 after acquiring an additional 598,002 shares during the last quarter. Jupiter Asset Management Ltd. acquired a new stake in shares of Cardinal Health during the first quarter worth $56,454,000. Jacobs Levy Equity Management Inc. raised its position in shares of Cardinal Health by 265.6% during the first quarter. Jacobs Levy Equity Management Inc. now owns 657,526 shares of the company’s stock worth $73,577,000 after purchasing an additional 477,682 shares during the period. Finally, Swedbank AB purchased a new stake in shares of Cardinal Health during the first quarter valued at $48,673,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Cardinal Health

In other news, insider Jessica L. Mayer sold 16,573 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $109.39, for a total value of $1,812,920.47. Following the sale, the insider now owns 75,971 shares of the company’s stock, valued at $8,310,467.69. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, insider Jessica L. Mayer sold 17,896 shares of Cardinal Health stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $106.48, for a total value of $1,905,566.08. Following the sale, the insider now owns 94,529 shares of the company’s stock, valued at approximately $10,065,447.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jessica L. Mayer sold 16,573 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $109.39, for a total value of $1,812,920.47. Following the transaction, the insider now directly owns 75,971 shares of the company’s stock, valued at $8,310,467.69. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 113,963 shares of company stock worth $12,379,980. Corporate insiders own 0.09% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Wells Fargo & Company raised their price objective on shares of Cardinal Health from $95.00 to $101.00 and gave the stock an “underweight” rating in a research note on Thursday, August 15th. UBS Group lifted their price target on Cardinal Health from $125.00 to $134.00 and gave the company a “buy” rating in a report on Tuesday, October 22nd. Evercore ISI increased their price objective on Cardinal Health from $105.00 to $115.00 and gave the stock an “in-line” rating in a research note on Thursday, August 15th. Robert W. Baird lifted their target price on Cardinal Health from $130.00 to $137.00 and gave the company an “outperform” rating in a research note on Thursday, August 15th. Finally, Argus increased their price target on shares of Cardinal Health from $115.00 to $125.00 and gave the stock a “buy” rating in a research report on Wednesday, September 11th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $121.64.

Cardinal Health Price Performance

NYSE CAH opened at $117.66 on Monday. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $119.13. The firm has a market cap of $28.47 billion, a P/E ratio of 33.56, a P/E/G ratio of 1.49 and a beta of 0.60. The stock’s 50-day moving average is $111.75 and its 200-day moving average is $104.17.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.64 by $0.24. The business had revenue of $52.28 billion for the quarter, compared to analysts’ expectations of $50.90 billion. Cardinal Health had a net margin of 0.37% and a negative return on equity of 54.85%. The firm’s revenue was down 4.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.73 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 7.61 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st were given a $0.506 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.72%. The ex-dividend date was Tuesday, October 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is currently 58.38%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.